Lindus Health
Private Company
Total funding raised: $24M
Overview
Lindus Health is a digital health-enabled CRO that positions itself as an 'Anti-CRO' by bundling clinical operations, site services, and proprietary technology into a single, integrated offering. Its value proposition centers on dramatically faster trial timelines (claiming 2-3x acceleration), cost certainty through milestone-based pricing, and high sponsor satisfaction. By leveraging direct access to electronic health records and an end-to-end software platform, Lindus aims to reduce the fragmentation and inefficiency that plague traditional clinical trial execution, primarily serving biotech and pharmaceutical sponsors.
Technology Platform
Proprietary end-to-end clinical trial technology platform enabling faster study startup and recruitment, including integrated clinical software tools and direct access to over 30 million electronic health records for patient identification.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes against large, global full-service CROs (e.g., IQVIA, Parexel, ICON) and a growing number of tech-enabled, niche CROs and site networks. Its differentiation is the combination of a full-service, 'All-in-One' offering with a deeply integrated proprietary tech platform and a fixed-price, milestone-based business model, which contrasts with the often fragmented and cost-plus structures of traditional players.